Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 238 publications
Improved overall survival in classical Hodgkin lymphoma across therapeutic eras: A National Cancer Database study.
Journal: British journal of haematology
Published: June 10, 2026
Erratum: Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 13, 2026
Autologous Stem Cell Transplant Consolidation Is Associated With Improved Overall Survival in Angioimmunoblastic T-Cell Lymphoma: A Real-World National Cancer Database Study.
Journal: Hematological oncology
Published: May 03, 2026
Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 16, 2026
Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma.
Journal: American journal of hematology
Published: March 25, 2026
Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trial.
Journal: Lancet (London, England)
Published: March 18, 2026
Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer database analysis.
Journal: Blood cancer journal
Published: March 10, 2026
Development and Validation of a Novel Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma.
Journal: American journal of hematology
Published: February 13, 2026
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience.
Journal: Blood cancer journal
Published: October 03, 2025
Primary Breast MALT Lymphoma: Clinical Features and Outcomes From a Single-Institution Experience at Mayo Clinic.
Journal: American journal of hematology
Published: September 25, 2025
Current treatment algorithm: diffuse large B cell lymphoma.
Journal: Blood cancer journal
Published: September 15, 2025
Last Updated: 09/26/2026